PortfoliosLab logoPortfoliosLab logo
BRK-B vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BRK-B vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Berkshire Hathaway Inc. (BRK-B) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BRK-B achieves a -2.67% return, which is significantly lower than MRK's 13.94% return. Over the past 10 years, BRK-B has outperformed MRK with an annualized return of 13.22%, while MRK has yielded a comparatively lower 11.59% annualized return.


BRK-B

1D
0.71%
1M
0.77%
YTD
-2.67%
6M
-2.06%
1Y
-0.22%
3Y*
13.30%
5Y*
11.27%
10Y*
13.22%

MRK

1D
-1.42%
1M
4.94%
YTD
13.94%
6M
20.60%
1Y
50.79%
3Y*
5.87%
5Y*
12.81%
10Y*
11.59%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BRK-B vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BRK-B
Berkshire Hathaway Inc.
-2.67%10.89%27.09%15.46%3.31%28.95%2.37%10.93%3.01%21.62%
MRK
Merck & Co., Inc.
13.94%9.79%-6.26%1.01%49.42%1.75%-7.20%22.27%39.95%-1.49%

Correlation

The correlation between BRK-B and MRK is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since May 9, 1996

0.28

Fundamentals

Market Cap

BRK-B:

$1.06T

MRK:

$294.29B

EPS

BRK-B:

$33.62

MRK:

$3.58

PE Ratio

BRK-B:

14.55

MRK:

33.21

PEG Ratio

BRK-B:

0.56

MRK:

0.03

PS Ratio

BRK-B:

2.81

MRK:

4.52

PB Ratio

BRK-B:

1.45

MRK:

6.41

Total Revenue (TTM)

BRK-B:

$375.39B

MRK:

$65.59B

Gross Profit (TTM)

BRK-B:

$94.36B

MRK:

$49.79B

EBITDA (TTM)

BRK-B:

$71.92B

MRK:

$22.69B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BRK-B vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BRK-B
BRK-B Risk / Return Rank: 3939
Overall Rank
BRK-B Sharpe Ratio Rank: 4242
Sharpe Ratio Rank
BRK-B Sortino Ratio Rank: 3434
Sortino Ratio Rank
BRK-B Omega Ratio Rank: 3333
Omega Ratio Rank
BRK-B Calmar Ratio Rank: 4242
Calmar Ratio Rank
BRK-B Martin Ratio Rank: 4242
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 8888
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8888
Sortino Ratio Rank
MRK Omega Ratio Rank: 8585
Omega Ratio Rank
MRK Calmar Ratio Rank: 9191
Calmar Ratio Rank
MRK Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BRK-B vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Berkshire Hathaway Inc. (BRK-B) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BRK-BMRKDifference
Sharpe ratioReturn per unit of total volatility

-1.90

Sortino ratioReturn per unit of downside risk

-2.72

Omega ratioGain probability vs. loss probability

1.01

1.33

-0.32

Calmar ratioReturn relative to maximum drawdown

-0.02

4.49

-4.51

Martin ratioReturn relative to average drawdown

-0.05

11.22

-11.26

BRK-B vs. MRK - Sharpe Ratio Comparison

The current BRK-B Sharpe Ratio is -0.02, which is lower than the MRK Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of BRK-B and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BRK-B vs. MRK - Drawdown Comparison

The maximum BRK-B drawdown since its inception was -53.86%, smaller than the maximum MRK drawdown of -68.61%. Use the drawdown chart below to compare losses from any high point for BRK-B and MRK.


Loading charts...

Drawdown Indicators


BRK-BMRKDifference

Max Drawdown

Largest peak-to-trough decline

-53.86%

-68.61%

+14.75%

Max Drawdown (1Y)

Largest decline over 1 year

-9.42%

-11.37%

+1.95%

Max Drawdown (3Y)

Largest decline over 3 years

-14.95%

-43.44%

+28.49%

Max Drawdown (5Y)

Largest decline over 5 years

-26.58%

-43.44%

+16.86%

Max Drawdown (10Y)

Largest decline over 10 years

-29.57%

-43.44%

+13.87%

Current Drawdown

Current decline from peak

-9.36%

-5.03%

-4.33%

Average Drawdown

Average peak-to-trough decline

-11.07%

-18.83%

+7.76%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

4.54%

-0.01%

Volatility

BRK-B vs. MRK - Volatility Comparison

The current volatility for Berkshire Hathaway Inc. (BRK-B) is 3.95%, while Merck & Co., Inc. (MRK) has a volatility of 9.57%. This indicates that BRK-B experiences smaller price fluctuations and is considered to be less risky than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BRK-BMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

3.95%

9.57%

-5.62%

Volatility (6M)

Calculated over the trailing 6-month period

10.78%

18.04%

-7.26%

Volatility (1Y)

Calculated over the trailing 1-year period

14.38%

27.18%

-12.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.12%

23.66%

-6.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.44%

22.96%

-3.52%

Dividends

BRK-B vs. MRK - Dividend Comparison

BRK-B has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 2.79%.


PositionTTM20252024202320222021202020192018201720162015
BRK-B
Berkshire Hathaway Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
2.79%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

BRK-B vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Berkshire Hathaway Inc. and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B20222023202420252026
93.68B
16.29B
(BRK-B) Total Revenue
(MRK) Total Revenue
Values in USD except per share items

BRK-B vs. MRK - Profitability Comparison

The chart below illustrates the profitability comparison between Berkshire Hathaway Inc. and Merck & Co., Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%80.0%20222023202420252026
28.8%
81.9%
Portfolio components
BRK-B - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Berkshire Hathaway Inc. reported a gross profit of 26.98B and revenue of 93.68B. Therefore, the gross margin over that period was 28.8%.

MRK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a gross profit of 13.34B and revenue of 16.29B. Therefore, the gross margin over that period was 81.9%.

BRK-B - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Berkshire Hathaway Inc. reported an operating income of 15.05B and revenue of 93.68B, resulting in an operating margin of 16.1%.

MRK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported an operating income of -1.88B and revenue of 16.29B, resulting in an operating margin of -11.6%.

BRK-B - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Berkshire Hathaway Inc. reported a net income of 10.18B and revenue of 93.68B, resulting in a net margin of 10.9%.

MRK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Merck & Co., Inc. reported a net income of -4.24B and revenue of 16.29B, resulting in a net margin of -26.0%.


Frequently Asked Questions


BRK-B and MRK have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MRK has higher volatility (9.57%) compared to BRK-B (3.95%). In terms of maximum drawdown, BRK-B dropped -53.86% vs MRK's -68.61%.

MRK currently has the higher Sharpe Ratio (1.88 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BRK-B and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer